MPM BioImpact LLC
SEC CIK 1687078 · EDGAR
BoughtSold
Most active insiders at HOWL, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | EVNIN LUKE | Dir | — | $3.26M |
| 2 | MPM BioVentures 2014 LLC | 10% | — | $1.09M |
| 3 | RA CAPITAL MANAGEMENT, L.P. | 10% | — | $963.9K |
| 4 | UBS Oncology Impact Fund L.P. | 10% | — | $824.5K |
| 5 | MPM Asset Management Investors BV2014 LLC | 10% | — | $528.5K |
| 6 | MPM Oncology Innovations Fund GP LLC | 10% | — | $528.1K |
| 7 | MPM BioImpact LLC | Former 10% Owner | — | $479.1K |
| 8 | MPM ONCOLOGY INNOVATIONS FUND LP | 10% | — | $391.6K |
| 9 | MPM BioVentures 2014, L.P. | 10% | — | $241.3K |
| 10 | MPM BioVentures 2014 (B), L.P. | Former 10% Owner | — | $183.3K |
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2025-12-04 | 2025-12-02+ | HOWL | Werewolf Therapeutics, Inc. | MPM BioImpact LLC | Former 10% Owner | S - Sale | $0.9176 | -199.7K | 4.78M | -4% | -$183.3K |
| MI | 2025-11-06 | 2025-11-04+ | HOWL | Werewolf Therapeutics, Inc. | MPM BioImpact LLC | 10% | S - Sale | $1.22 | -242.9K | 6.01M | -4% | -$295.8K |
| 2021-09-20 | 2021-09-16 | CGEM | Cullinan Therapeutics, Inc. | BioImpact Capital LLC | 10% | S - Sale | $29.06 | -3,124 | 7.65M | -0.0% | -$90.8K | |
| M | 2021-09-16 | 2021-09-14+ | CGEM | Cullinan Therapeutics, Inc. | BioImpact Capital LLC | 10% | S - Sale | $29.17 | -13.5K | 7.66M | -0.2% | -$394.6K |
| M | 2021-09-13 | 2021-09-09+ | CGEM | Cullinan Therapeutics, Inc. | BioImpact Capital LLC | 10% | S - Sale | $29.23 | -23.3K | 7.66M | -0.3% | -$679.7K |
| M | 2021-09-08 | 2021-09-03+ | CGEM | Cullinan Therapeutics, Inc. | BioImpact Capital LLC | 10% | S - Sale | $29.20 | -48.6K | 7.69M | -0.6% | -$1.42M |
Purchase Sale Sale after option exercise All abbreviations